grey market retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and Drug Company linked to raid on

From there, protein support and electrolytes are commonly added as part of a more balanced routine

With the help of CU Anschutz Innovations, the research team launched a startup to further advance these new therapies and will soon find if their fundamental discovery works

Plus Wimbledon heads for it's 9th straight first time winner on the women's side.LinksOur football World Cup thread, for Supporters Club members, containing all the Mexico-England analysis and more discussion on the tournamentMovistar under fire as Uijtdebroeks races on while illThe Stanford Glove - researchers thought they'd found a way to 'hack' cooling with a Zoolander like vacuum gloveBBC article on Josh Kerr's 3:42 target preparationsKerr on the importance of psychology in his preparationThe Nature paper on men vs women pacing strategies in the marathon 14

While Wegovy is the only Semaglutide product specifically approved by the FDA for weight loss (Novo), its counterparts, Ozempic and Rybelsus, are only approved for managing diabetes (FDA U.S